Lipid pharmacotherapy for treatment of atherosclerosis
Date
2014
Authors
Nicholls, S.
Pisaniello, A.
Kataoka, Y.
Puri, R.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Expert Opinion on Pharmacotherapy, 2014; 15(8):1119-1125
Statement of Responsibility
Stephen J Nicholls, Anthony D Pisaniello, Yu Kataoka & Rishi Puri
Conference Name
Abstract
INTRODUCTION: For more than two decades, lowering levels of low-density lipoprotein cholesterol has formed the cornerstone of management of patients with atherosclerotic cardiovascular disease. The substantial residual risk of clinical events in patients treated with statin therapy highlights the need to develop more effective strategies to reduce cardiovascular risk. AREAS COVERED: Current and future approaches targeting dyslipidemia and inflammatory factors implicated in atherosclerosis are discussed. EXPERT OPINION: Considerable efforts to further reduce levels of atherogenic lipoproteins provide additional strategies to lower cardiovascular risk. In contrast, it remains to be determined whether targeting protective lipid factors or inflammatory mediators of atherosclerosis will be clinically beneficial.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2014 Informa UK